Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2006 1
2007 1
2008 5
2009 6
2010 6
2011 2
2016 3
2017 3
2018 1
2019 2
2020 2
2021 1
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Serotonergic perturbations in dystonia disorders-a systematic review.
Smit M, Bartels AL, van Faassen M, Kuiper A, Niezen-Koning KE, Kema IP, Dierckx RA, de Koning TJ, Tijssen MA. Smit M, et al. Among authors: bartels al. Neurosci Biobehav Rev. 2016 Jun;65:264-75. doi: 10.1016/j.neubiorev.2016.03.015. Epub 2016 Apr 9. Neurosci Biobehav Rev. 2016. PMID: 27073048 Review.
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET.
Mossel P, Arif WM, De Souza GS, Varela LG, van der Weijden CWJ, Boersma HH, Willemsen ATM, Boellaard R, Elsinga PH, Borra RJH, Dierckx RAJO, Lammertsma AA, Bartels AL, Luurtsema G. Mossel P, et al. Among authors: bartels al. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3917-3927. doi: 10.1007/s00259-023-06363-5. Epub 2023 Aug 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 37552369 Free PMC article.
Evaluation of P-glycoprotein function at the blood-brain barrier using [18F]MC225-PET.
Mossel P, Garcia Varela L, Arif WM, van der Weijden CWJ, Boersma HH, Willemsen ATM, Boellaard R, Elsinga PH, Borra RJH, Colabufo NA, Toyohara J, de Deyn PP, Dierckx RAJO, Lammertsma AA, Bartels AL, Luurtsema G. Mossel P, et al. Among authors: bartels al. Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4105-4106. doi: 10.1007/s00259-021-05419-8. Epub 2021 Jun 5. Eur J Nucl Med Mol Imaging. 2021. PMID: 34089347 Free PMC article. No abstract available.
Fecal microbiome alterations in treatment-naive de novo Parkinson's disease.
Boertien JM, Murtomäki K, Pereira PAB, van der Zee S, Mertsalmi TH, Levo R, Nojonen T, Mäkinen E, Jaakkola E, Laine P, Paulin L, Pekkonen E, Kaasinen V, Auvinen P, Scheperjans F, van Laar T; PPNN Study Group. Boertien JM, et al. NPJ Parkinsons Dis. 2022 Oct 10;8(1):129. doi: 10.1038/s41531-022-00395-8. NPJ Parkinsons Dis. 2022. PMID: 36216843 Free PMC article.
Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET.
Garcia-Varela L, Mossel P, Aguiar P, Vazquez-Matias DA, van Waarde A, Willemsen ATM, Bartels AL, Colabufo NA, Dierckx RAJO, Elsinga PH, Luurtsema G. Garcia-Varela L, et al. Among authors: bartels al. J Control Release. 2022 Jul;347:500-507. doi: 10.1016/j.jconrel.2022.05.026. Epub 2022 May 20. J Control Release. 2022. PMID: 35588934 Free article.
39 results